Neonatal Sepsis Questions & Answers

1. Klinger G, Levy I, Sirota L, et al, for the Israel Neonatal Network. Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants. Am J Obstet Gynecol. 2009 Jul. 201 (1):38.e1-6. [Medline].

2. van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010. 97 (1):22-8. [Medline].

3. [Guideline] Verani JR, McGee L, Schrag SJ, for the Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010 Nov 19. 59 (RR-10):1-36. [Medline]. [Full Text].

4. Berardi A, Rossi C, Spada C, et al, for the GBS Prevention Working Group of Emilia-Romagna. Strategies for preventing early-onset sepsis and for managing neonates at-risk: wide variability across six Western countries. J Matern Fetal Neonatal Med. 2019 Sep. 32 (18):3102-8. [Medline].

5. Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J. 2011 Sep. 30 (9):759-63. [Medline]. [Full Text].

6. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011 Nov. 30 (11):937-41. [Medline].

7. Morales WJ, Dickey SS, Bornick P, Lim DV. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol. 1999 Aug. 181 (2):310-4. [Medline].

8. Strunk T, Richmond P, Simmer K, Currie A, Levy O, Burgner D. Neonatal immune responses to coagulase-negative staphylococci. Curr Opin Infect Dis. 2007 Aug. 20 (4):370-5. [Medline].

9. Power Coombs MR, Kronforst K, Levy O. Neonatal host defense against Staphylococcal infections. Clin Dev Immunol. 2013. 2013:826303. [Medline].

10. Srinivasan L, Kirpalani H, Cotten CM. Elucidating the role of genomics in neonatal sepsis. Semin Perinatol. 2015 Dec. 39 (8):611-6. [Medline].

11. Groer MW, Gregory KE, Louis-Jacques A, Thibeau S, Walker WA. The very low birth weight infant microbiome and childhood health. Birth Defects Res C Embryo Today. 2015 Dec. 105 (4):252-64. [Medline].

12. Koenig JM, Yoder MC. Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatol. 2004 Mar. 31 (1):39-51. [Medline].

13. Weinberg AG, Rosenfeld CR, Manroe BL, Browne R. Neonatal blood cell count in health and disease. II. Values for lymphocytes, monocytes, and eosinophils. J Pediatr. 1985 Mar. 106 (3):462-6. [Medline].

14. Landor M. Maternal-fetal transfer of immunoglobulins. Ann Allergy Asthma Immunol. 1995 Apr. 74 (4):279-83; quiz 284. [Medline].

15. Griffiths PD, Stagno S, Pass RF, Smith RJ, Alford CA Jr. Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics. 1982 May. 69 (5):544-9. [Medline].

16. Kohler PF. Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis. J Clin Invest. 1973 Mar. 52 (3):671-7. [Medline].

17. Stocker J, Dehner L, eds. Pediatric Pathology. Vol 2. Philadelphia, PA: JB Lippincott; 1992.

18. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis. 2008 Jun. 21 (3):223-7. [Medline].

19. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014 Jan. 27 (1):21-47. [Medline].

20. Graham PL 3rd, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risk factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J. 2006 Feb. 25 (2):113-7. [Medline].

21. Stoll BJ, Hansen NI, Sánchez PJ, et al, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011 May. 127 (5):817-26. [Medline].

22. American Academy of Pediatrics. Red Book 2003: Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. 117-123, 237-43, 561-73, 584-91.

23. American Academy of Pediatrics. Red Book 2018-2021: Report of the Committee on Infectious Diseases. 31st ed. Elk Grove Village, IL: American Academy of Pediatrics; 2018.

24. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee opinion no. 485: Prevention of early-onset group B streptococcal disease in newborns (reaffirmed in 2016). Obstet Gynecol. 2011 Apr. 117 (4):1019-27. [Medline]. [Full Text].

25. [Guideline] Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002 Aug 16. 51 (RR-11):1-22. [Medline].

26. Mukhopadhyay S, Lieberman ES, Puopolo KM, Riley LE, Johnson LC. Effect of early-onset sepsis evaluations on in-hospital breastfeeding practices among asymptomatic term neonates. Hosp Pediatr. 2015 Apr. 5 (4):203-10. [Medline].

27. Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med. 2008 Mar. 9 (2):186-91. [Medline].

28. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006 Jun. 19 (3):290-7. [Medline].

29. Volpe JJ. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr. 2008 Aug. 153 (2):160-3. [Medline]. [Full Text].

30. Stoll BJ, Hansen NI, Adams-Chapman I, et al, for the National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004 Nov 17. 292 (19):2357-65. [Medline].

31. Seaward PG, Hannah ME, Myhr TL, et al. International multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. Premature Rupture of the Membranes. Am J Obstet Gynecol. 1998 Sep. 179 (3 Pt 1):635-9. [Medline].

32. Committee on Obstetric Practice. Committee opinion no. 712: Intrapartum management of intraamniotic infection. Obstet Gynecol. 2017 Aug. 130 (2):e95-e101. [Medline]. [Full Text].

33. Peng CC, Chang JH, Lin HY, Cheng PJ, Su BH. Intrauterine inflammation, infection, or both (triple I): a new concept for chorioamnionitis. Pediatr Neonatol. 2018 Jun. 59 (3):231-7. [Medline].

34. Kuzniewicz MW, Walsh EM, Li S, Fischer A, Escobar GJ. Development and implementation of an early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates. Jt Comm J Qual Patient Saf. 2016 May. 42 (5):232-9. [Medline].

35. Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011 Nov. 128 (5):e1155-63. [Medline].

36. Short MA. Guide to a systematic physical assessment in the infant with suspected infection and/or sepsis. Adv Neonatal Care. 2004 Jun. 4 (3):141-53; quiz 154-7. [Medline].

37. Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta. 2015 Dec 7. 451 (pt A):46-64. [Medline].

38. Chan KY, Lam HS, Cheung HM, et al. Rapid identification and differentiation of Gram-negative and Gram-positive bacterial bloodstream infections by quantitative polymerase chain reaction in preterm infants. Crit Care Med. 2009 Aug. 37 (8):2441-7. [Medline].

39. Enomoto M, Morioka I, Morisawa T, Yokoyama N, Matsuo M. A novel diagnostic tool for detecting neonatal infections using multiplex polymerase chain reaction. Neonatology. 2009. 96 (2):102-8. [Medline].

40. Mukhopadhyay S, Puopolo KM. Clinical and microbiologic characteristics of early-onset sepsis among very low birth weight infants: opportunities for antibiotic stewardship. Pediatr Infect Dis J. 2017 May. 36 (5):477-81. [Medline].

41. Carroll PD, Christensen RD. New and underutilized uses of umbilical cord blood in neonatal care. Matern Health Neonatol Perinatol. 2015. 1:16. [Medline].

42. Khashu M, Osiovich H, Henry D, Al Khotani A, Solimano A, Speert DP. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics. 2006 Feb. 117 (2):340-8. [Medline].

43. Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics. 2010 Nov. 126 (5):903-9. [Medline].

44. Hawk M. C-reactive protein in neonatal sepsis. Neonatal Netw. 2008 Mar-Apr. 27 (2):117-20. [Medline].

45. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr. 2006 Apr. 18 (2):125-31. [Medline].

46. Boskabadi H, Zakerihamidi M. Evaluate the diagnosis of neonatal sepsis by measuring interleukins: A systematic review. Pediatr Neonatol. 2018 Aug. 59 (4):329-38. [Medline]. [Full Text].

47. Leal YA, Alvarez-Nemegyei J, Lavadores-May AI, Giron-Carrillo JL, Cedillo-Rivera R, Velazquez JR. Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med. 2019 Sep. 32 (17):2830-6. [Medline].

48. van Maldeghem I, Nusman CM, Visser DH. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis. BMC Immunol. 2019 Jun 3. 20 (1):17. [Medline]. [Full Text].

49. Meem M, Modak JK, Mortuza R, Morshed M, Islam MS, Saha SK. Biomarkers for diagnosis of neonatal infections: a systematic analysis of their potential as a point-of-care diagnostics. J Glob Health. 2011 Dec. 1 (2):201-9. [Medline].

50. Altunhan H, Annagur A, Ors R, Mehmetoglu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011 Dec. 15 (12):e854-8. [Medline].

51. Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med. 2018 Jun. 31 (12):1646-59. [Medline].

52. Ng PC, Li K, Leung TF, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem. 2006 Jun. 52 (6):1181-9. [Medline].

53. Garges HP, Moody MA, Cotten CM, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics. 2006 Apr. 117 (4):1094-100. [Medline].

54. Davis KL, Shah SS, Frank G, Eppes SC. Why are young infants tested for herpes simplex virus?. Pediatr Emerg Care. 2008 Oct. 24 (10):673-8. [Medline].

55. Ting JY, Synnes A, Roberts A, et al, for the Canadian Neonatal Network Investigators. Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr. 2016 Dec 1. 170 (12):1181-7. [Medline].

56. Tzialla C, Borghesi A, Pozzi M, Stronati M. Neonatal infections due to multi-resistant strains: epidemiology, current treatment, emerging therapeutic approaches and prevention. Clin Chim Acta. 2015 Dec 7. 451 (Pt A):71-7. [Medline].

57. Shipp KD, Chiang T, Karasick S, Quick K, Nguyen ST, Cantey JB. Antibiotic stewardship challenges in a referral neonatal intensive care unit. Am J Perinatol. 2016 Apr. 33 (5):518-24. [Medline].

58. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006 Jan. 117 (1):67-74. [Medline].

59. Zaidi AK, Tikmani SS, Warraich HJ, et al. Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens. Pediatr Infect Dis J. 2012 Jul. 31 (7):667-72. [Medline].

60. Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics. 2000 Mar. 105 (3 pt 1):523-7. [Medline].

61. Brocklehurst P, Farrell B, King A, et al, for the INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011 Sep 29. 365 (13):1201-11. [Medline].

62. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996 May 31. 45 (RR-7):1-24. [Medline].

63. [Guideline] American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007 Oct. 120 (4):898-921. [Medline]. [Full Text].

64. [Guideline] American Academy of Audiology. American Academy of Audiology position statement and clinical practice guidelines: ototoxicity monitoring. 2009 Oct. 1-25. [Full Text].

65. Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol. 2006 Jan 1. 26 (1):18-22. [Medline].

66. Geethanath RM, Ahmed I, Abu-Harb M, Onwuneme C, McGarry K, Hinshaw K. Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis. J Obstet Gynaecol. 2019 Jul. 39 (5):619-22. [Medline].

67. Sawyer T, Billimoria Z, Handley S, et al. Therapeutic plasma exchange in neonatal septic shock: a retrospective cohort study. Am J Perinatol. 2019 Jun 8. [Medline].

Nathan S Gollehon, MD, FAAP Assistant Professor of Pediatrics, Neonatologist, Division of Neonatal-Perinatal Medicine, Pediatrics Clerkship Director, Children’s Hospital and Medical Center, University of Nebraska Medical Center

Nathan S Gollehon, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Physicians, American Medical Association

Disclosure: Nothing to disclose.

Ann L Anderson-Berry, MD, PhD Associate Professor of Pediatrics, Section of Newborn Medicine, University of Nebraska Medical Center, Creighton University School of Medicine; Medical Director, NICU, Nebraska Medical Center

Ann L Anderson-Berry, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, Nebraska Medical Association, Society for Pediatric Research

Disclosure: Nothing to disclose.

Muhammad Aslam, MD Professor of Pediatrics, University of California, Irvine, School of Medicine; Neonatologist, Division of Newborn Medicine, Department of Pediatrics, UC Irvine Medical Center

Muhammad Aslam, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Linda L Bellig, RN, MA, NNP-BC (Retired) Track Coordinator, Instructor, Neonatal Nurse Practitioner Program, Medical University of South Carolina College of Nursing

Disclosure: Nothing to disclose.

Bryan L Ohning, MD, PhD Medical Director of Neonatal Transport, Division of Neonatology, Children's Hospital, Greenville Hospital System, University Medical Center; Professor of Clinical Pediatrics, University of South Carolina School of Medicine-Greenville

Bryan L Ohning, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, South Carolina Medical Association

Disclosure: Receive salary from Pediatrix Medical Group of SC for employment. for: Mednax.

David A Clark, MD Chairman, Professor, Department of Pediatrics, Albany Medical College

David A Clark, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Pediatric Society, Christian Medical & Dental Society, Medical Society of the State of New York, New York Academy of Sciences, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Scott S MacGilvray, MD Clinical Professor, Department of Pediatrics, Division of Neonatology, The Brody School of Medicine at East Carolina University

Scott S MacGilvray, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article